We designed this study to investigate the potential use of N‐acetylcysteine (NAC) as an adjunct to alpha‐blockers in the treatment of category III chronic prostatitis (CP). Click to show full abstract
We designed this study to investigate the potential use of N‐acetylcysteine (NAC) as an adjunct to alpha‐blockers in the treatment of category III chronic prostatitis (CP).
               
Click one of the above tabs to view related content.